Home › Stocks › PBM › Changes

Who bought & sold PBM (Q3 2026)

Funds holding (Q3 2026)10
New positions2
Added3
Reduced2
Exited1

As of Q3 2026, 10 institutional funds reported holding PBM (PSYENCE BIOMEDICAL LTD): 2 opened new positions, 3 added, 2 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (2)

Fund Shares Value Weight
Rockefeller Capital Management L.P. New 235 $1.28K —
JPMorgan Chase & Co New 11 $60 —

Added to positions (3)

Fund Shares Value Weight Change
AdvisorShares Investments LLC 258.54K $1.41M 0.2 +136.35K sh (+111.6%)
Citadel Advisors 13.46K $73.50K — +1.77K sh (+15.1%)
UBS Group AG 330 $1.80K — +270 sh (+450.0%)

Reduced positions (2)

Fund Shares Value Weight Change
JANE STREET GROUP, LLC 16.24K $88.67K — -14.19K sh (-46.6%)
Morgan Stanley 33.54K $183.13K — -4.26K sh (-11.3%)

Exited positions (1)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
XTX Topco Ltd Exited 15.09K $46.19K 0.0